Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

FDA approves Lupin’s Livalo generic Nikita
FDA approves Lupin’s Livalo generic Nikita
SILVER SPRING, Md.
Type 1 diabetes may be halted by experimental immunotherapy
Type 1 diabetes may be halted by experimental immunotherapy
An immunotherapy approach for treating type 1 diabetes has been found to be safe for the first time, and seems to stop the condition from getting worse.
Trump Plans to Declare Opioid Epidemic a National Emergency
Trump Plans to Declare Opioid Epidemic a National Emergency
WASHINGTON — President Trump said on Thursday that he was preparing to officially declare the United States’ worsening epidemic of opioid overdoses as a national emergency, accepting an urgent rec...
Alzheimer's drugs market forecast to expand at 7.5% CAGR to 2025
Alzheimer's drugs market forecast to expand at 7.5% CAGR to 2025
Allergan (NYSE.
Humira may spend most on TV, but Xeljanz, Taltz and Breo notch highest view rates
Humira may spend most on TV, but Xeljanz, Taltz and Breo notch highest view rates
When it comes to TV ads, many consumers—and doctors—claim no one wants to see them.
Mexico watchdog finds big pharma faces no competition on some drugs
Mexico watchdog finds big pharma faces no competition on some drugs
 MEXICO CITY (Reuters) - Major drugmakers including GlaxoSmithKline Plc and Pfizer Inc face no competition in Mexico from generics that are readily available elsewhere, partly because of regu...
Australia vitamin 'breakthrough' to cut miscarriages, birth defects
Australia vitamin 'breakthrough' to cut miscarriages, birth defects
Taking a common vitamin supplement could significantly reduce the number of miscarriages and birth defects worldwide, Australian scientists said Thursday, in what they described as a major breakthroug...
Teva gets FDA clearance for QVAR RediHaler
Teva gets FDA clearance for QVAR RediHaler
SILVER SPRING, Md.
FDA green-lights CMP Pharma’s CaroSpir
FDA green-lights CMP Pharma’s CaroSpir
SILVER SPRING, Md.
Perrigo gets tentative FDA approval for Mirvaso gel generic
Perrigo gets tentative FDA approval for Mirvaso gel generic
SILVER SPRING, Md.
Teva intros generic Relpax
Teva intros generic Relpax
NORTH WALES, Pa.
Mylan given green light to launch Avonza in India
Mylan given green light to launch Avonza in India
Netherlands-based drugmaker Mylan (Nasdaq.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand